Stránka klinických studií Nct
Clinical Trial Results:
A phase Ib study investigating the combination of RAD001 with trastuzumab and vinorelbine in patients with HER2- overexpressing metastatic breast cancer
| Summary | |
EudraCT number | 2006-001595-20 |
Trial protocol | IT |
Global completion date | 15 Jun 2010 |
| Paediatric regulatory details | |
Is the trial part of an agreed EMA paediatric investigation plan? | No |
Is the trial in scope of article 45 of Regulation (EC) No 1901/2006? | No |
Is the trial in scope of article 46 of Regulation (EC) No 1901/2006? | No |
| Results information | |
Results version number | v1(current) |
This version publication date | 15 Dec 2016 |
First version publication date | 15 Dec 2016 |
Other versions | |
Summary report(s) | CRAD001J2102.CTR.02Nov2016 |
Note: The legislation allows summary attachments to be posted instead of the full dataset for this trial. Refer to Commission Guideline 2012/C 302/03 for further information.